Skip to main content

Table 4 Sum B-mode (BM) scores of the different joint combinations during the study

From: Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis

 

Baseline

1 month

3 months

6 monhts

12 months

7-joint score

11.5 (1 to 22)

7.5 (0 to 20)*

6.5 (0 to 15)*

7.0 (0 to 17)**

5.5 (0 to 16)**

12-joint score

15.0 (0 to 52)

12.5 (0 to 37)*

11.0 (0 to 28)*

9.5 (0 to 32)*

7.5 (0 to 28)*

28-joint score

17.0 (2 to 65)

13.0 (2 to 57)**

11.0 (0 to 45)**

8.5 (1 to 45)*

12.0 (0 to 45)*

44-joint score

40.0 (6 to 131)

31.5 (3 to 103)**

29.5 (6 to 71)**

19.5 (1 to 69)**

20.0 (1 to 73)**

78-joint score

53.5 (6 to 154)

38.5 (3 to 124)**

36.5 (6 to 96)**

23.5 (1 to 91)**

27.0 (1 to 101)**

  1. Sum BM scores of the different joint combinations at baseline and after 1, 3, 6 and 12 months. All joint combinations showed significant change from baseline (* = P ≤ 0.05, ** = P ≤ 0.001).